PTGX· Protagonist Therapeutics Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 7 | $14M |
Quarterly ownership history
Last 6 quarters
PTGX Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$6.4B
Enterprise value$5.9B
EV / EBITDA (TTM)-41.50
P/E ratio (TTM)—
Forward P/E-266.38
P/S ratio86.28
P/B ratio10.12
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$117M
Free cash flow (TTM)-$78M
Total cash$548M
Total debt$10M
Debt / equity1.49
Current ratio17.76
Income Statement
Total revenue (TTM)$74M
Revenue per share (TTM)1.16
Gross profit (TTM)$74M
EBITDA (TTM)-$141M
Net income (TTM)-$115M
EPS diluted (TTM)-1.81
Shares outstanding64,311,373
Float shares52,684,520
Profitability
Gross margin100.00%
Operating margin-6.47%
EBITDA margin-190.40%
Net margin-154.88%
Efficiency
Return on assets (TTM)-12.37%
Return on equity (TTM)-17.06%
Price History
Current price$99.36
52 Week high$107.84
52 Week low$43.20
50 day average$99.75
200 day average$80.88
Average volume (10 day)644,730
1-year beta1.88
1-year price target$115.83
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:41 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com